Boundless Bio (BOLD) filed a mixed shelf registration statement to raise $400 million from the sale of any combination of several securities, according to a Tuesday filing.
The filing covers common stock, preferred stock, debt securities, warrants, and units.
The sale of the securities will be held "from time to time," the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.